These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 19174935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Refractory gastrooesophageal reflux disease.
    Bredenoord AJ, Smout AJ.
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):217-23. PubMed ID: 18301303
    [Abstract] [Full Text] [Related]

  • 3. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB.
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [Abstract] [Full Text] [Related]

  • 4. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [Abstract] [Full Text] [Related]

  • 5. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V, Bajbouj M, Waller K, Schmid RM, Meining A.
    Aliment Pharmacol Ther; 2007 Nov 15; 26(10):1355-60. PubMed ID: 17900268
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y, Fujiwara Y, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T.
    J Gastroenterol Hepatol; 2012 Apr 15; 27 Suppl 3():58-62. PubMed ID: 22486873
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I.
    Aliment Pharmacol Ther; 2006 Mar 15; 23 Suppl 1():12-24. PubMed ID: 16483266
    [Abstract] [Full Text] [Related]

  • 16. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D, Tutuian R.
    Best Pract Res Clin Gastroenterol; 2009 Mar 15; 23(3):299-311. PubMed ID: 19505660
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.
    Sifrim D, Zerbib F.
    Gut; 2012 Sep 15; 61(9):1340-54. PubMed ID: 22684483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evidence and uncertainties on the clinical use of proton pump inhibitors].
    de Prados CM.
    Gastroenterol Hepatol; 2010 May 15; 33 Suppl 1():5-10. PubMed ID: 20728783
    [Abstract] [Full Text] [Related]

  • 20. [pH-impedancemetry: clinical implications].
    Bertolini D, Roman S, Dumonceau JM.
    Rev Med Suisse; 2008 Sep 03; 4(169):1873-4, 1876-8. PubMed ID: 18831408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.